Helen Benghiat
- Genetics top 10%
- Glioma Diagnosis and Treatment 9
- Neurology top 10%
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 2
-
- Brain Metastases and Treatment 6
-
- Meningioma and schwannoma management 6
-
- Adrenal Hormones and Disorders 3
- Pituitary Gland Disorders and Treatments 2
-
- Cancer, Hypoxia, and Metabolism 2
-
- Lung Cancer Research Studies 2
- Co-authors
- Paul SangheraA. HartleyHelena GleesonAndrew ToogoodElizabeth CrowneDannis G. van VuurdenMaura MassiminoStéphanie Bolle
- Cited by
- GeneticsNeurologyOtorhinolaryngology
- Journals
- SHILAP Revista de lepidopterología (1 paper)European Journal of Cancer (1 paper)Radiotherapy and Oncology (1 paper)
- Partner nations
- United KingdomSpainSwitzerland
In The Last Decade
Helen Benghiat
16 papers receiving 236 citations
Peers
Comparison fields: 5 of 37
- Genetics 140
- Neurology 98
- Otorhinolaryngology 24
- Pulmonary and Respiratory Medicine 96
- Radiation 20
Countries citing papers authored by Helen Benghiat
This map shows the geographic impact of Helen Benghiat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Benghiat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Benghiat more than expected).
Fields of papers citing papers by Helen Benghiat
This network shows the impact of papers produced by Helen Benghiat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Benghiat. The network helps show where Helen Benghiat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen Benghiat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 11 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 1 | |
| 7 | 2018 | 2 | |
| 8 | 2018 | 16 | |
| 9 | 2018 | 30 | |
| 10 | 2018 | 1 | |
| 11 | 2017 | 89 | |
| 12 | 2016 | 8 | |
| 13 | 2015 | 40 | |
| 14 | 2014 | 19 | |
| 15 | 2014 | 13 | |
| 16 | 2011 | 1 | |
| 17 | 2009 | 5 |
About Helen Benghiat
Helen Benghiat is a scholar working on Genetics, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 240 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (9 papers), Brain Metastases and Treatment (6 papers), Meningioma and schwannoma management (6 papers), Adrenal Hormones and Disorders (3 papers), Pituitary Gland Disorders and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Head and Neck Cancer Studies (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Genetics (140 citations), Neurology (98 citations) and Otorhinolaryngology (24 citations). Helen Benghiat has collaborated with scholars based in United Kingdom, Spain and Switzerland. Frequent co-authors include Paul Sanghera, A. Hartley, Helena Gleeson, Andrew Toogood, Elizabeth Crowne, Dannis G. van Vuurden, Maura Massimino, Stéphanie Bolle, Henry Mandeville and Geert O. Janssens. Their work appears in journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.